AzTrials
AzTrials

DrainagePhase 2/3CT-NavNCT00828893

Navigation Guidance Gestures Carried Out Under CT

A Phase 2/3 study testing navigation station in people with Drainage and Biopsy, run by AdministrateurCIC at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to assess the contribution of navigation systems recently developed to guide the punction needle. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Drainage, Biopsy, Punction
What is being tested?
navigation station
Type of treatment
Medical device
How many people
120 participants
Where
1 siteFrance
Study dates
Oct 2009to Jan 2012
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • more or equal than 18 years old
  • patient affiliated to social security or similarly regime
  • patient sent to hospital for drain under CT

Who cannot join

  • Pregnant women and lactating mothers
  • Ward of court or under guardianship
  • Adult unable to express their consent
  • Person deprived of freedom by judicial or administrative decision
  • Person hospitalized without their consent
  • Person under legal protection
  • Person participating in another clinical study

Trial locations and contacts

1 site in 1 country.

France1 site
  • UniversityHospitalGrenoble

    Grenoble

Other trials in France

About this study

Official title: Interest of the Use of a Navigation Guidance Gestures Carried Out Under CT

The purpose of this study is to assess the contribution of navigation systems recently developed to guide the punction needle.

Being tested
navigation station
Keywords
drain under scanner

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • navigation stationDevice

    navigation station for gestures (carried out under CT) guidance

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximum distance between the planned trajectory and trajectory achieved, defined for the needle of local anesthesia.

    Measured: 2 hours

Secondary outcomes (7)
  1. Maximum distance between the planned trajectory and trajectory achieved by the needle puncture.

    Measured: 2 hours

  2. Duration of intervention

    Measured: 3 hours

  3. Dose irradiation and number of control scanners made

    Measured: 3 hours

  4. overall satisfaction Score

    Measured: 3 hours

  5. Success or failure of the final gesture made

    Measured: 3 hours

  6. Number of attempts

    Measured: 3 hours

  7. number of complications (per-operative, post-surgery)

    Measured: 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2009 (estimated)
  2. Study startOct 2009
  3. Primary completionJan 2012
  4. Study completionJan 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00828893
Sponsor's protocol ID
DCIC 08 01
Other IDs
IMACTIS company
Acronym
CT-Nav
Status last verified
Feb 2012
First submitted
23 Jan 2009
Last updated
20 Feb 2012
Results posted
No
Data monitoring committee
Yes

Publications

  • Robert AL, Chagnon G, Bricault I, Cinquin P, Moreau-Gaudry A. A generic three-dimensional static force distribution basis for a medical needle inserted into soft tissue. J Mech Behav Biomed Mater. 2013 Dec;28:156-70. doi: 10.1016/j.jmbbm.2013.07.023. Epub 2013 Aug 9.

    PubMed 23988636

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing navigation station in people with Drainage and Biopsy, run by AdministrateurCIC at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Feb 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximum distance between the planned trajectory and trajectory achieved, defined for the needle of local anesthesia. (time frame: 2 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00828893, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in